These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1815055)

  • 21. A versatile computational method for the determination of areas under the curve and moment curve following multidose drug administration.
    Yamashita TS; Lee HL; Reed MD
    Int J Biomed Comput; 1988 Dec; 23(3-4):239-49. PubMed ID: 3225062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of vindesine given as an intravenous bolus and 24-hour infusion in humans.
    Ohnuma T; Norton L; Andrejczuk A; Holland JF
    Cancer Res; 1985 Jan; 45(1):464-9. PubMed ID: 3965152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of ivermectin administered intravenously to cattle.
    Wilkinson PK; Pope DG; Baylis FP
    J Pharm Sci; 1985 Oct; 74(10):1105-7. PubMed ID: 3841151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel method of calculating absolute bioavailability in nonlinear pharmacokinetics.
    Veng-Pedersen P
    J Pharm Sci; 1985 Jan; 74(1):90-3. PubMed ID: 3981428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of trimethoprim in the rat.
    Tu YH; Allen LV; Fiorica VM; Albers DD
    J Pharm Sci; 1989 Jul; 78(7):556-60. PubMed ID: 2778654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of pralidoxime chloride in the rat.
    Green MD; Talbot BG; Clark CR
    Life Sci; 1986 Dec; 39(23):2263-9. PubMed ID: 3784779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Validation of a new procedure for calculating tissue/blood distribution coefficient].
    Manuĭlov KK; Gefter IuV
    Antibiot Khimioter; 1991 Mar; 36(3):49-50. PubMed ID: 1877880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of age on the pharmacokinetic parameters of digoxin].
    Korkushko OV; Orlov PA; Bezverkhaia IS; Belyĭ AA
    Farmakol Toksikol; 1984; 47(3):101-4. PubMed ID: 6734802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination of inulin clearance by bolus intravenous injection in healthy subjects and ascitic patients: equivalence of systemic and renal clearances as glomerular filtration markers.
    Orlando R; Floreani M; Padrini R; Palatini P
    Br J Clin Pharmacol; 1998 Dec; 46(6):605-9. PubMed ID: 9862251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A population pharmacokinetic/pharmacodynamic analysis of regadenoson, an adenosine A2A-receptor agonist, in healthy male volunteers.
    Gordi T; Frohna P; Sun HL; Wolff A; Belardinelli L; Lieu H
    Clin Pharmacokinet; 2006; 45(12):1201-12. PubMed ID: 17112296
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Value of the theory of the optimal sampling scheme for bioequivalence studies].
    Tod M; Petitjean O; Nicolas P
    Therapie; 1993; 48(1):7-13. PubMed ID: 8356559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Volumes of distribution and mean residence time of drugs with linear tissue distribution and binding and nonlinear protein binding.
    Cheng H; Gillespie WR
    J Pharmacokinet Biopharm; 1996 Aug; 24(4):389-402. PubMed ID: 9044167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Numerical estimation of the noncompartmental pharmacokinetic parameters variance and coefficient of variation of residence times.
    Purves RD
    J Pharm Sci; 1994 Feb; 83(2):202-5. PubMed ID: 8169789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Linear relationships in systems with non linear kinetics.
    Fagiolino P; Savio E; Stareczek S
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():485-96. PubMed ID: 1820928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Absolute oral bioavailability of traxoprodil in cytochrome P450 2D6 extensive and poor metabolisers.
    Taylor TJ; Diringer K; Russell T; Venkatakrishnan K; Wilner K; Crownover PH; Benincosa LJ; Gibbs MA
    Clin Pharmacokinet; 2006; 45(10):989-1001. PubMed ID: 16984212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A nonlinear tissue-binding model for creatine: estimation of creatine turnover time and creatinine production rate.
    Boroujerdi M
    Res Commun Chem Pathol Pharmacol; 1986 Sep; 53(3):361-71. PubMed ID: 3775104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An area function method for calculating the apparent elimination rate constant of a metabolite.
    Cheng HY; Jusko WJ
    J Pharmacokinet Biopharm; 1989 Feb; 17(1):125-30. PubMed ID: 2715930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of the possibility of the secondary peaks of iv bolus drug plasma concentration time curve by the model that directly takes into account the transit time through the organ.
    Berezhkovskiy LM
    J Pharm Sci; 2009 Nov; 98(11):4376-90. PubMed ID: 19340884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of renal impairment on the pharmacokinetics and safety of fosfluconazole and fluconazole following a single intravenous bolus injection of fosfluconazole.
    Sobue S; Tan K; Layton G; Leclerc V; Weil A
    Br J Clin Pharmacol; 2004 Jun; 57(6):773-84. PubMed ID: 15151523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diltiazem pharmacokinetics in the rat and relationship between its serum concentration and uterine and cardiovascular effects.
    Downing SJ; Edwards D; Hollingsworth M
    Br J Pharmacol; 1987 Aug; 91(4):735-45. PubMed ID: 3664075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.